<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36976797</PMID><DateCompleted><Year>2023</Year><Month>04</Month><Day>18</Day></DateCompleted><DateRevised><Year>2024</Year><Month>03</Month><Day>13</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1522-1547</ISSN><JournalIssue CitedMedium="Internet"><Volume>324</Volume><Issue>5</Issue><PubDate><Year>2023</Year><Month>May</Month><Day>01</Day></PubDate></JournalIssue><Title>American journal of physiology. Gastrointestinal and liver physiology</Title><ISOAbbreviation>Am J Physiol Gastrointest Liver Physiol</ISOAbbreviation></Journal><ArticleTitle>Is intestinal transport dysfunctional in COVID-19-related diarrhea?</ArticleTitle><Pagination><StartPage>G415</StartPage><EndPage>G418</EndPage><MedlinePgn>G415-G418</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1152/ajpgi.00021.2023</ELocationID><Abstract><AbstractText>Diarrhea, often severe, is a recognized and frequently early symptom during acute COVID-19 infection and may persist or develop for the first time in patients with long-COVID, with socioeconomic consequences. Diarrheal mechanisms in these cases are poorly understood. There is evidence for disruption of intestinal epithelial barrier function and also for changes in the gut microbiome, which is critical for gut immunity and metabolism. Whether the SARS-CoV-2 virus has adverse effects on intestinal transport proteins is unclear. However, the ability of the virus to inhibit expression and activity of an aldosterone-regulated epithelial sodium (Na<sup>+</sup>) channel (ENaC) present in human distal colon, which is responsible for Na<sup>+</sup> and water salvage, points to possible disruption of other intestinal transport proteins during COVID-19 infection. In this Perspective, we develop this idea by highlighting possible intestinal transport protein targets for the SARS-CoV-2 virus and discussing how their interactions might be explored in the laboratory.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sandle</LastName><ForeName>Geoffrey I</ForeName><Initials>GI</Initials><Identifier Source="ORCID">0000-0002-6956-4168</Identifier><AffiliationInfo><Affiliation>Leeds Institute for Medical Research at St. James's, St. James's University Hospital, Leeds, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Herod</LastName><ForeName>Morgan R</ForeName><Initials>MR</Initials><AffiliationInfo><Affiliation>Astbury Centre for Structural Molecular Biology, University of Leeds, Leeds, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fontana</LastName><ForeName>Juan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Astbury Centre for Structural Molecular Biology, University of Leeds, Leeds, United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty of Biological Sciences, University of Leeds, Leeds, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lippiat</LastName><ForeName>Jonathan D</ForeName><Initials>JD</Initials><AffiliationInfo><Affiliation>Faculty of Biological Sciences, University of Leeds, Leeds, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stockley</LastName><ForeName>Peter G</ForeName><Initials>PG</Initials><AffiliationInfo><Affiliation>Astbury Centre for Structural Molecular Biology, University of Leeds, Leeds, United Kingdom.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>MR/S007229/1</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016421">Editorial</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>03</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Am J Physiol Gastrointest Liver Physiol</MedlineTA><NlmUniqueID>100901227</NlmUniqueID><ISSNLinking>0193-1857</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D053503">Epithelial Sodium Channels</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D053503" MajorTopicYN="N">Epithelial Sodium Channels</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003967" MajorTopicYN="N">Diarrhea</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">diarrhea</Keyword><Keyword MajorTopicYN="N">intestine</Keyword><Keyword MajorTopicYN="N">transport</Keyword></KeywordList><CoiStatement>No conflicts of interest, financial or otherwise, are declared by the authors.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>4</Month><Day>18</Day><Hour>6</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>3</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>3</Month><Day>28</Day><Hour>13</Hour><Minute>33</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>3</Month><Day>28</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36976797</ArticleId><ArticleId IdType="pmc">PMC10281778</ArticleId><ArticleId IdType="doi">10.1152/ajpgi.00021.2023</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>D'Amico F, Baumgart DC, Danese S, Peyrin-Biroulet L. Diarrhea during COVID-19 infection: pathogenesis, epidemiology, prevention, and management. Clin Gastroenterol Hepatol 18: 1663&#x2013;1672, 2020. doi:10.1016/j.cgh.2020.04.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cgh.2020.04.001</ArticleId><ArticleId IdType="pmc">PMC7141637</ArticleId><ArticleId IdType="pubmed">32278065</ArticleId></ArticleIdList></Reference><Reference><Citation>Bogariu AM, Dumitrascu DL. Digestive involvement in the long-COVID syndrome. Med Pharm Rep 95: 5&#x2013;10, 2022. doi:10.15386/mpr-2340.</Citation><ArticleIdList><ArticleId IdType="doi">10.15386/mpr-2340</ArticleId><ArticleId IdType="pmc">PMC9177081</ArticleId><ArticleId IdType="pubmed">35720240</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoffmann M, Kleine-Weber H, Schroeder S, Kr&#xfc;ger N, Herrier T, Erichsen S, Schiergens TS, Herrier G, Wu N-H, Nitsche A, M&#xfc;ller MA, Drosten C, P&#xf6;hlmann S. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell 181: 271&#x2013;280.e8, 2020. doi:10.1016/j.cell.2020.02.052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.02.052</ArticleId><ArticleId IdType="pmc">PMC7102627</ArticleId><ArticleId IdType="pubmed">32142651</ArticleId></ArticleIdList></Reference><Reference><Citation>Xia S, Lan Q, Su S, Wang X, Xu W, Liu Z, Zhu Y, Wang Q, Lu L, Jiang S. The role of furin cleavage site in SARS-CoV-2 spike protein-mediated membrane fusion in the presence or absence of trypsin. Signal Transduct Target Ther 5: 92, 2020. doi:10.1038/s41392-020-0184-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-020-0184-0</ArticleId><ArticleId IdType="pmc">PMC7289711</ArticleId><ArticleId IdType="pubmed">32532959</ArticleId></ArticleIdList></Reference><Reference><Citation>McFadyen DJ, Stevens H, Karlheinz P. The emerging threat of (micro)thrombosis in COVID-19 and its therapeutic implications. Circ Res 127: 571&#x2013;587, 2020. doi:10.1161/CIRCRESAHA.120.317447.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.120.317447</ArticleId><ArticleId IdType="pmc">PMC7386875</ArticleId><ArticleId IdType="pubmed">32586214</ArticleId></ArticleIdList></Reference><Reference><Citation>Burchill E, Lymberopoulos E, Menozzi E, Budhdeo S, McLLory JR, Macnaughtan J, Sharma N. The unique impact of COVID-19 on human gut microbiome research. Front Med (Lausanne) 8: 652464, 2021. doi:10.3389/fmed.2021.652464.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2021.652464</ArticleId><ArticleId IdType="pmc">PMC8007773</ArticleId><ArticleId IdType="pubmed">33796545</ArticleId></ArticleIdList></Reference><Reference><Citation>Paparo L, Maglio MA, Cortese M, Bruno C, Capasso M, Punzo E, Ferrucci V, Lasorsa VA, Viscardi M, Fusco G, Cerino P, Romano A, Troncone R, Zollo MA. A new butyrate releaser exerts a protective action against SARS-CoV-2 infection in human intestine. Molecules 27: 862, 2022. doi:10.3390/molecules27030862.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules27030862</ArticleId><ArticleId IdType="pmc">PMC8838168</ArticleId><ArticleId IdType="pubmed">35164139</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan R, Zhang Y, Li Y, Xia L, Guo Y, Zhou Q. Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2. Science 367: 1444&#x2013;1448, 2020. doi:10.1126/science.abb2762.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abb2762</ArticleId><ArticleId IdType="pmc">PMC7164635</ArticleId><ArticleId IdType="pubmed">32132184</ArticleId></ArticleIdList></Reference><Reference><Citation>Neurath M. Cytokines in inflammatory bowel disease. Nat Rev Immunol 14: 329&#x2013;342, 2014. doi:10.1038/nri3661.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri3661</ArticleId><ArticleId IdType="pubmed">24751956</ArticleId></ArticleIdList></Reference><Reference><Citation>Kellett GL, Brot-Laroche E, Mace OJ, Leturque A. Sugar absorption in the intestine: the role of GLUT2. Ann Rev Nutr 28: 35&#x2013;54, 2008. doi:10.1146/annurev.nutr.28.061807.155518.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev.nutr.28.061807.155518</ArticleId><ArticleId IdType="pubmed">18393659</ArticleId></ArticleIdList></Reference><Reference><Citation>Staub O, Gautschi I, Ishikawa T, Breitschopf K, Ciechanover A, Schild L, Rotin D. Regulation of stability and function of the epithelial Na+ channel (ENaC) by ubiquitination. EMBO J 16: 6325&#x2013;6336, 1997. doi:10.1093/emboj/16.21.6325.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/emboj/16.21.6325</ArticleId><ArticleId IdType="pmc">PMC1170239</ArticleId><ArticleId IdType="pubmed">9351815</ArticleId></ArticleIdList></Reference><Reference><Citation>Ji H-L, Song W, Gao Z, Su X-F, Nie H-G, Jiang Y, Peng J-B, He Y-X, Liao Y, Zhou Y-J, Tousson A, Matalon S. SARS-CoV proteins decrease levels and activity of human ENaC via activation of distinct PKC isoforms. Am J Physiol Lung Cell Mol Physiol 296: L372&#x2013;L383, 2009. doi:10.1152/ajplung.90437.2008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajplung.90437.2008</ArticleId><ArticleId IdType="pmc">PMC2660211</ArticleId><ArticleId IdType="pubmed">19112100</ArticleId></ArticleIdList></Reference><Reference><Citation>Anand P, Puranik A, Aravamudan M, Venkatakrishnan AJ, Soundararajan V. SARS-CoV-2 strategically mimics proteolytic activation of human ENaC. eLife 9: e58603, 2020. doi:10.7554/eLife.58603.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.58603</ArticleId><ArticleId IdType="pmc">PMC7343387</ArticleId><ArticleId IdType="pubmed">32452762</ArticleId></ArticleIdList></Reference><Reference><Citation>Amasheh S, Barmeyer C, Koch CS, Tavalali S, Mankertz J, Epple H-J, Gehring MM, Florian P, Kroesen A-J, Zeitz M, Fromm M, Schulzke J-D. Cytokine-dependent transcriptional down-regulation of epithelial sodium channel in ulcerative colitis. Gastroenterology 126: 1711&#x2013;1720, 2004. doi:10.1053/j.gastro.2004.03.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2004.03.010</ArticleId><ArticleId IdType="pubmed">15188166</ArticleId></ArticleIdList></Reference><Reference><Citation>Sandle GI, Perry MD, Mathialahan T, Linley JE, Robinson P, Hunter M, MacLennan KA. Altered cryptal expression of luminal potassium (BK) channels in ulcerative colitis. J Pathol 212: 66&#x2013;73, 2007. doi:10.1002/path.2159.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/path.2159</ArticleId><ArticleId IdType="pubmed">17405186</ArticleId></ArticleIdList></Reference><Reference><Citation>Rajendran VM, Sandle GI. Colonic potassium absorption and secretion in health and disease. Compr Physiol 8: 1513&#x2013;1536, 2018. doi:10.1002/cphy.c170030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cphy.c170030</ArticleId><ArticleId IdType="pmc">PMC9769410</ArticleId><ArticleId IdType="pubmed">30215859</ArticleId></ArticleIdList></Reference><Reference><Citation>Perry MD, Sandle GI. Regulation of colonic apical potassium (BK) channels by cAMP and somatostatin. Am J Physiol Gastrointest Liver Physiol 297: G159&#x2013;G167, 2009. doi:10.1152/ajpgi.00132.2009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpgi.00132.2009</ArticleId><ArticleId IdType="pmc">PMC2711756</ArticleId><ArticleId IdType="pubmed">19407217</ArticleId></ArticleIdList></Reference><Reference><Citation>Stutts MJ, Rossier BC, Boucher RC. Cystic fibrosis transmembrane conductance regulator inverts protein kinase A-mediated regulation of epithelial sodium channel single channel kinetics. J Biol Chem 272: 14037&#x2013;14040, 1997. doi:10.1074/jbc.272.22.14037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.272.22.14037</ArticleId><ArticleId IdType="pubmed">9162024</ArticleId></ArticleIdList></Reference><Reference><Citation>Wiederkehr MR, Zhao H, Moe OW. Acute regulation of Na/H exchanger NHE3 activity by protein kinase C: role of NHE3 phosphorylation. Am J Physiol Cell Physiol 276: C1205&#x2013;C1217, 1999. doi:10.1152/ajpcell.1999.276.5.c1205.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpcell.1999.276.5.c1205</ArticleId><ArticleId IdType="pubmed">10329970</ArticleId></ArticleIdList></Reference><Reference><Citation>Singla A, Kumar A, Priyamvada S, Tahniyath M, Saksena S, Gill RK, Alreai WA, Dudeja PK. LPA stimulates intestinal DRA gene transcription via LPA2 receptor, PI3K/AKT, and c-Fos-dependent pathway. Am J Physiol Gastrointest Liver Physiol 302: G618&#x2013;G627, 2012. doi:10.1152/ajpgi.00172.2011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpgi.00172.2011</ArticleId><ArticleId IdType="pmc">PMC3311307</ArticleId><ArticleId IdType="pubmed">22159277</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu Q. Slc26a3 (DRA) in the gut: expression, function, regulation, role in infectious diarrhea and inflammatory bowel disease. Inflamm Bowel Dis 27: 575&#x2013;584, 2021. doi:10.1093/ibd/izaa256.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ibd/izaa256</ArticleId><ArticleId IdType="pubmed">32989468</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Hazza A, Linley JE, Aziz Q, MacLennan KA, Hunter M, Sandle GI. Potential role of reduced basolateral potassium (IKCa3.1) channel expression in the pathogenesis of diarrhoea in ulcerative colitis. J Pathol 226: 463&#x2013;470, 2012. doi:10.1002/path.2994.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/path.2994</ArticleId><ArticleId IdType="pubmed">22009605</ArticleId></ArticleIdList></Reference><Reference><Citation>Khan S, Shafiei MS, Longoria C, Schoggins JW, Savani RC, Zaki H. SARS-CoV-2 spike protein induces inflammation via TLR2-dependent activation of the NF-&#x3ba;B pathway. eLife 10: e68563, 2021. doi:10.7554/eLife.68563.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.68563</ArticleId><ArticleId IdType="pmc">PMC8709575</ArticleId><ArticleId IdType="pubmed">34866574</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>